Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Knowing when to modify your financial plan is essential for optimal results. Discover key indicators that signal it's time for adjustments.
23,050 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
New York City is weighing luxury levies that could affect private jets. Here’s how jet owners can prepare for potenti...
A cardinal tetra’s journey from the Amazon to home tanks reveals how the global aquarium trade touches personal finan...
A common retirement pitfall hinges on COBRA coverage not extending Medicare enrollment windows. This piece explains h...
A new period of market volatility and plan underfunding concerns spotlight four retirement mistakes that cost electri...
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Can Bitcoin surge to $100,000 by the end of 2026? This article breaks down the forces that could push BTC higher, the...
AI is reshaping markets faster than many investors expect. This no-brainer artificial intelligence (AI) stock story b...
IBM stock soaring today has traders buzzing, but a one-day gain is only part of the story. This guide breaks down the...
When a biotech company’s leader sells shares, it can raise questions for investors. This guide breaks down how to int...
Hyped up rare-earth plays attract attention, but many stumble before they mine. This guide breaks down how to assess ...